• Tue news: 23andMe CEO no longer open to takeover. mRNA vaccines may boost cancer immunotherapy. BMS beats $6.4B lawsuit. CVS Health layoffs and potential breakup. JNJ abandoning proposed 340b plan. See more on our front page

Core Therapeutic Areas

Anonymous

Guest
“We will sharpen our focus on core therapeutic areas,” Frazier said on a conference call. That means more resources for vaccines, cancer, diabetes and hospital care. “In other therapeutic areas, we will significantly reduce our resources.”
 

<



Similar threads

Replies
2
Views
1K
Merck
Anonymous
Replies
4
Views
776
Merck
Anonymous
Replies
1
Views
647
Merck
Anonymous
Replies
2
Views
1K
Merck
anonymous